Cdk2 activation acts upstream of the mitochondrion during glucocorticoid induced thymocyte apoptosis

Eur J Immunol. 2004 Oct;34(10):2781-90. doi: 10.1002/eji.200425154.

Abstract

Thymocytes undergo apoptosis during negative selection in vivo and following treatment with glucocorticoids or DNA-damaging drugs in vitro. The post-mitochondrial biochemical steps leading to apoptosis induced by these stimuli are well characterized, however, much less is known about the pathways connecting receptor triggering, apical caspase activation and induction of mitochondrial dysfunction. These stimuli specifically activate the kinase Cdk2 and this step is obligatory for these forms of thymocyte apoptosis. We report here that Cdk2 activation is a very early step during thymocyte apoptosis preceding apical caspase activation and phosphatidylserine exposure. Furthermore, Cdk2 activation is required for mitochondrial permeability disruption, cytochrome c release and, as a consequence, activation of the downstream caspases 9 and 3. Our data allow an integrated linear pathway regulating DNA damage and glucocorticoid-induced thymocyte apoptosis to be proposed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / immunology*
  • CDC2-CDC28 Kinases / drug effects
  • CDC2-CDC28 Kinases / metabolism*
  • Caspases / metabolism
  • Cyclin-Dependent Kinase 2
  • Enzyme Activation / drug effects
  • Enzyme Activation / physiology*
  • Glucocorticoids / pharmacology
  • Immunoblotting
  • Mice
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Models, Immunological
  • Signal Transduction / immunology
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology*

Substances

  • Glucocorticoids
  • CDC2-CDC28 Kinases
  • Cdk2 protein, mouse
  • Cyclin-Dependent Kinase 2
  • Caspases